Literature DB >> 21657836

Cancer biomarkers, companion diagnostics and personalized oncology.

Jeffrey S Ross1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21657836     DOI: 10.2217/bmm.11.29

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  12 in total

1.  A rational free energy-based approach to understanding and targeting disease-causing missense mutations.

Authors:  Zhe Zhang; Shawn Witham; Marharita Petukh; Gautier Moroy; Maria Miteva; Yoshihiko Ikeguchi; Emil Alexov
Journal:  J Am Med Inform Assoc       Date:  2013-02-13       Impact factor: 4.497

2.  Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.

Authors:  Julia R Trosman; Christine B Weldon; R Kate Kelley; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

Review 3.  From drug discovery to biomarker-driven clinical trials in lymphoma.

Authors:  Anas Younes; Donald A Berry
Journal:  Nat Rev Clin Oncol       Date:  2012-09-11       Impact factor: 66.675

4.  Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Authors:  Julian C Schink; Julia R Trosman; Christine B Weldon; Kalliopi P Siziopikou; Gregory J Tsongalis; Alfred W Rademaker; Jyoti D Patel; Al B Benson; Edith A Perez; William J Gradishar
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

5.  Paradigms for Precision Medicine in Epichaperome Cancer Therapy.

Authors:  Nagavarakishore Pillarsetty; Komal Jhaveri; Tony Taldone; Eloisi Caldas-Lopes; Blesida Punzalan; Suhasini Joshi; Alexander Bolaender; Mohammad M Uddin; Anna Rodina; Pengrong Yan; Anson Ku; Thomas Ku; Smit K Shah; Serge Lyashchenko; Eva Burnazi; Tai Wang; Nicolas Lecomte; Yelena Janjigian; Anas Younes; Connie W Batlevi; Monica L Guzman; Gail J Roboz; Jacek Koziorowski; Pat Zanzonico; Mary L Alpaugh; Adriana Corben; Shanu Modi; Larry Norton; Steven M Larson; Jason S Lewis; Gabriela Chiosis; John F Gerecitano; Mark P S Dunphy
Journal:  Cancer Cell       Date:  2019-10-24       Impact factor: 31.743

6.  Molecular profiling for personalized cancer care.

Authors:  Raheela Ashfaq
Journal:  Clin Exp Metastasis       Date:  2012-06-08       Impact factor: 5.150

7.  SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care.

Authors:  Jeremy L Warner; Matthew J Rioth; Kenneth D Mandl; Joshua C Mandel; David A Kreda; Isaac S Kohane; Daniel Carbone; Ross Oreto; Lucy Wang; Shilin Zhu; Heming Yao; Gil Alterovitz
Journal:  J Am Med Inform Assoc       Date:  2016-03-27       Impact factor: 7.942

8.  Nuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro.

Authors:  Sandra Sernbo; Carl A K Borrebaeck; Mathias Uhlén; Karin Jirström; Sara Ek
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

Review 9.  Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.

Authors:  Hala Fawzy Mohamed Kamel; Hiba Saeed A Bagader Al-Amodi
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-08-13       Impact factor: 7.691

Review 10.  Clinical application of genetics to guide prevention and treatment of oral diseases.

Authors:  K S Kornman; P J Polverini
Journal:  Clin Genet       Date:  2014-05-10       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.